NCT06217107 Wellness & Workforce Solution for Lupus/Lupus Nephritis
| NCT ID | NCT06217107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Morehouse School of Medicine |
| Condition | Lupus Nephritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-09-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2024-09-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will test the hypothesis that culturally congruent coaching delivered via a technology application (Health360x) will improve the persistent disparities observed among women of color with lupus or lupus nephritis by addressing underlying psychosocial barriers to behavioral change.
Eligibility Criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. females ; Age over 18yo 4. Self-reported diagnosis of Lupus or Lupus Nephritis, or documented diagnosis of Lupus or Lupus Nephritis 5. Willingness to adhere to the study intervention regimen 6. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart-phone, internet access) 7. Not currently practicing self-management behaviors and have not participated in a class or program on self-management behavior within the last 12 months Adult women with lupus and lupus nephritis will be enrolled in the study. Eligibility: Adult women with lupus and lupus nephritis who are able to consent and participate in self-management support training. Access to the internet is required for this intervention. Ability to read English is required because all the materials are currently in English. Coaches must meet all of the following criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for duration of study 3. Women of color with lupus or lupus nephritis with desire to help others 4. Ability to communicate in English 5. Secure access to Internet 6. Private space for conducting participant visits 7. Ability to use internet-based platform Exclusion Criteria: -Potential participants and coaches who are unable to speak or read English, access the internet, or complete data collection activities will be ineligible for participation.
Contact & Investigator
Priscilla Pemu, MD
PRINCIPAL INVESTIGATOR
MSM Director of Clinical Research Center
Frequently Asked Questions
Who can join the NCT06217107 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Lupus Nephritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06217107 currently recruiting?
Yes, NCT06217107 is actively recruiting participants. Contact the research team at cIbeawuchi@msm.edu for enrollment information.
Where is the NCT06217107 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT06217107 clinical trial?
NCT06217107 is sponsored by Morehouse School of Medicine. The principal investigator is Priscilla Pemu, MD at MSM Director of Clinical Research Center. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.